Auckland Clinical Studies

  • ACS provides state-of-the-art world class research facilities and the expertise to perform Phase I and II studies for the pharmaceutical and biotechnology industry.
  • ACS is an early-phase clinical pharmacology unit established in 2006. Located directly adjacent to Auckland City Hospital, ACS has established an extremely close relationship with the specialist doctors based at that institution, other Auckland hospitals and private specialists. ACS has developed an enviable reputation in patient studies, particularly in areas of hepatology, oncology and dermatology. ACS has also conducted many trials in healthy volunteers ranging from entry-in-human single ascending dose studies to bioavailability/food effect assessments. We have experience conducting studies that start in healthy volunteers and move into patients under one protocol.
  • ACS works in close cooperation with CCST, its Christchurch based sister company that has developed a reputation for excellence in Phase I and II research since 1999. ACS is able to offer full or tailored CRO services when required.

ACS is a Certified Clinical Trial site with the New Zealand Medicines and Medical Devices Safety Authority (Medsafe)

Professor Ed Gane receiving the 2014 Health Research Council of New Zealand’s distinguished Liley Medal

Dr. Ed Gane

We would like to congratulate our colleague Professor Ed Gane for receiving the 2014 Health Research Council of New Zealand’s distinguished Liley Medal for demonstrating a safer, more effective treatment for people with hepatitis C virus. The Liley Medal recognises Professor Gane’s outstanding contribution to the health and medical sciences in the field of clinical hepatology. Professor Gane was the lead author on two very highly cited papers in the prestigious medical journal, New England Journal of Medicine, which showed that people could be cured of the hepatitis C virus in just 12 weeks using an antiviral treatment called sofosbuvir. A significant proportion of the research leading to this prestigious award was conducted at Auckland Clinical Studies. We would also like to use this opportunity to thank the more than 500 patients who have participated in Hepatitis C studies at ACS over the last few years and have made this outstanding progress in the treatment of this devastating disease possible.